Daratumumab Plus Atezolizumab in Previously Treated Advanced or Metastatic NSCLC: Brief Report on a Randomized, Open-Label, Phase 1b/2 Study (LUC2001 JNJ-54767414)

por Pillai, Rathi N., Ramalingam, Suresh S., Thayu, Meena, Lorenzini, Patricia, Alvarez Arias, Diana A., Moy, Christopher, Hutnick, Natalie, Knoblauch, Roland, Feng, Huaibao, Kane, Colleen, Horn, Leora, Reck, Martin, Ponce, Santiago
Publicado 2020